{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:46:46Z","timestamp":1792633606647,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.survophthal.2006.10.003","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T09:59:32Z","timestamp":1168250372000},"page":"13-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Botulinum Toxin in Ophthalmology"],"prefix":"10.1016","volume":"52","author":[{"given":"Jonathan J.","family":"Dutton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy M.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 5","key":"10.1016\/j.survophthal.2006.10.003_bib1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/eye.1987.93","article-title":"Botulinum toxin A induced protective ptosis","volume":"1","author":"Adams","year":"1987","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2006.10.003_bib2","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/mds.20098","article-title":"Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia","volume":"19","author":"Adler","year":"2004","journal-title":"Mov Disord"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2006.10.003_bib3","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1046\/j.1526-4610.43.7s.3.x","article-title":"Evidence for antinociceptive activity of botulinum toxin type A in pain management","volume":"43","author":"Aoki","year":"2003","journal-title":"Headache"},{"issue":"Suppl 5","key":"10.1016\/j.survophthal.2006.10.003_bib4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1468-1331.2001.00035.x","article-title":"Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions","volume":"8","author":"Aoki","year":"2001","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2273.1996.tb01018.x","article-title":"Treatment of facial synkinesis and facial asymmetry with botulinum toxin type A following facial nerve palsy","volume":"21","author":"Armstrong","year":"1996","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00055735-200312000-00005","article-title":"Migraine: an ophthalmologist's perspective","volume":"14","author":"Arunagiri","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"issue":"Suppl 8","key":"10.1016\/j.survophthal.2006.10.003_bib7","first-page":"S68","article-title":"Basic immunological aspects of botulinum toxin therapy","volume":"19","author":"Atazzi","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.survophthal.2006.10.003_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11940-999-0034-4","article-title":"Acquired nystagmus","volume":"1","author":"Averbuch-Heller","year":"1999","journal-title":"Curr Treat Options Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1113\/jphysiol.1987.sp016356","article-title":"Acetylcholine receptors and sodium channels in denervated and botulinum-toxin-treated adult rat muscle","volume":"382","author":"Bambrick","year":"1987","journal-title":"J Physiol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00041327-200412000-00003","article-title":"Chronic myokymia limited to the eyelid is a benign condition","volume":"24","author":"Banik","year":"2004","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib11","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bjo.2003.029181","article-title":"Long term efficacy and safety of botulinum toxin A injection for crocodile tears syndrome","volume":"88","author":"Bara\u00f1ano","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1526-4610.2003.03210.x","article-title":"Single-site botulinum toxin type a injection for elimination of migraine trigger points","volume":"43","author":"Behmand","year":"2003","journal-title":"Headache"},{"issue":"Pt 5","key":"10.1016\/j.survophthal.2006.10.003_bib13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/eye.1995.139","article-title":"Management of strabismus due to orbital myositis","volume":"9","author":"Bessant","year":"1995","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2006.10.003_bib14","first-page":"186","article-title":"Control of eyelid retraction associated with Graves' disease with botulinum A toxin","volume":"25","author":"Biglan","year":"1994","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S1064-7406(03)00076-2","article-title":"Treatment of migraine headache with botulinum toxin type A","volume":"11","author":"Binder","year":"2003","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.survophthal.2006.10.003_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1054\/bjps.1998.3058","article-title":"Botulinum toxoid in the management of gustatory sweating (Frey's syndrome) after superficial parotidectomy","volume":"52","author":"Birch","year":"1999","journal-title":"Br J Plast Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0733-8635(03)00105-0","article-title":"Botulinum neurotoxin for the treatment of migraine and other primary headache disorders","volume":"22","author":"Blumenfeld","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1749-6632.2002.tb02861.x","article-title":"Botulinum toxin therapy for apraxia of lid opening","volume":"956","author":"Boghen","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00002018-199411030-00001","article-title":"New concepts in botulinum toxin therapy","volume":"11","author":"Borodic","year":"1994","journal-title":"Drug Saf"},{"key":"10.1016\/j.survophthal.2006.10.003_bib20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature03123","article-title":"Substrate recognition strategy for botulinum neurotoxin serotype A","volume":"432","author":"Breidenbach","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.survophthal.2006.10.003_bib21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/PL00007849","article-title":"Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm","volume":"249","author":"Cakmur","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/112067210301300401","article-title":"Treatment of blepharospasm with botulinum neurotoxin type A: long-term results","volume":"13","author":"Calace","year":"2003","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.clindermatol.2003.12.027","article-title":"Botulinum toxin type B (Myobloc): pharmacology and biochemistry","volume":"22","author":"Callaway","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3928\/0191-3913-20001101-05","article-title":"Critical age of botulinum toxin treatment in essential infantile esotropia","volume":"37","author":"Campos","year":"2000","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2006.10.003_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clindermatol.2003.11.003","article-title":"History of the clinical use of botulinum toxin A and B","volume":"21","author":"Carruthers","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib26","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0733-8635(03)00071-8","article-title":"Botulinum toxin type A for the treatment of glabellar rhytides","volume":"22","author":"Carruthers","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3928\/0191-3913-19950901-09","article-title":"The treatment of congenital nystagmus with Botox","volume":"32","author":"Carruthers","year":"1995","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2006.10.003_bib28","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0733-8635(03)00118-9","article-title":"Botulinum toxin A in the mid and lower face and neck","volume":"22","author":"Carruthers","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib29","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1097\/01.PRS.0000144795.76040.D3","article-title":"Consensus recommendations on the use of botulinum toxin type A in facial aesthetics","volume":"114","author":"Carruthers","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1017\/S0317167100026159","article-title":"Botulinum toxin for benign essential blepharospasm, hemifacial spasm and age-related lower eyelid entropion","volume":"14","author":"Carruthers","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib31","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/ajhp\/61.suppl_6.S11","article-title":"Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses","volume":"61","author":"Charles","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.survophthal.2006.10.003_bib32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1064-7406(03)00072-5","article-title":"Altering brow contour with botulinum toxin","volume":"11","author":"Chen","year":"2003","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1016\/j.survophthal.2006.10.003_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/01676830490512233","article-title":"Treatment of aberrant facial nerve regeneration with botulinum toxin A","volume":"23","author":"Chua","year":"2004","journal-title":"Orbit"},{"key":"10.1016\/j.survophthal.2006.10.003_bib34","first-page":"1051","article-title":"Botulinum toxin treatment for upper lid retraction of dysthyroidism","volume":"86","author":"Chuenkongkaew","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.survophthal.2006.10.003_bib35","first-page":"171","article-title":"Botulinum toxin treatment of the sixth nerve palsy: an experience of 5-year duration in Thailand","volume":"84","author":"Chuenkongkaew","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.survophthal.2006.10.003_bib36","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bjo.72.5.361","article-title":"Treatment of senile entropion with botulinum toxin","volume":"72","author":"Clarke","year":"1988","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib37","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002826-198610000-00002","article-title":"Botulinum injection therapy for blepharospasm: a review and report of 75 patients","volume":"9","author":"Cohen","year":"1986","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/mus.20033","article-title":"Botulinum toxins in neurological disease","volume":"29","author":"Comella","year":"2004","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.survophthal.2006.10.003_bib39","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bjo.74.5.309","article-title":"Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm","volume":"74","author":"Corridan","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib40","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1097\/00002508-200211001-00004","article-title":"Considering the immune response to botulinum toxin","volume":"18","author":"Critchfield","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.survophthal.2006.10.003_bib41","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1055\/s-2008-1054448","article-title":"[Treatment of nystagmus using injections of botulinum toxins into the eye muscles]","volume":"184","author":"Crone","year":"1984","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.survophthal.2006.10.003_bib42","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09273970490522902","article-title":"Does botulinum toxin have a role in the treatment of small-angle esotropia","volume":"12","author":"Dawson","year":"2004","journal-title":"Strabismus"},{"key":"10.1016\/j.survophthal.2006.10.003_bib43","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0161-6420(99)90360-3","article-title":"The role of botulinum toxin A in acute-onset esotropia","volume":"106","author":"Dawson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000007935","article-title":"Isolated so-called apraxia of eyelid opening: report of 10 cases and a review of the literature","volume":"39","author":"Defazio","year":"1998","journal-title":"Eur Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00347-004-1091-4","article-title":"[Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease]","volume":"102","author":"Dintelmann","year":"2005","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.survophthal.2006.10.003_bib46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.clindermatol.2003.12.031","article-title":"Botulinum neurotoxin for the treatment of migraine and other primary headache disorders","volume":"22","author":"Dodick","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1081\/IMM-120016244","article-title":"Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response","volume":"31","author":"Dolimbek","year":"2002","journal-title":"Immunol Invest"},{"key":"10.1016\/j.survophthal.2006.10.003_bib48","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/307457a0","article-title":"Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization","volume":"307","author":"Dolly","year":"1984","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2006.10.003_bib49","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.1093\/clinids\/6.Supplement_1.S202","article-title":"Botulism and tetanus: selected epidemiologic and microbiologic aspects","volume":"6","author":"Dowell","year":"1984","journal-title":"Rev Infect Dis"},{"issue":"Suppl 8","key":"10.1016\/j.survophthal.2006.10.003_bib50","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1002\/mds.20022","article-title":"Clinical presentation and management of antibody-induced failure of botulinum toxin therapy","volume":"19","author":"Dressler","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.survophthal.2006.10.003_bib51","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mds.1238","article-title":"Botulinum toxin antibody type A titres after cessation of botulinum toxin therapy","volume":"17","author":"Dressler","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.survophthal.2006.10.003_bib52","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00415-003-1129-6","article-title":"Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure","volume":"250","author":"Dressler","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib53","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000047963","article-title":"Antibody-induced botulinum toxin therapy failure: can it be overcome by increased botulinum toxin doses?","volume":"47","author":"Dressler","year":"2002","journal-title":"Eur Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib54","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0039-6257(97)81995-9","article-title":"Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects","volume":"41","author":"Dutton","year":"1996","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib55","series-title":"Therapy With Botulinum Toxin","first-page":"199","article-title":"Acute and chronic effects of botulinum toxin in the management of blepharospasm","author":"Dutton","year":"1994"},{"key":"10.1016\/j.survophthal.2006.10.003_bib56","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","article-title":"Long-term results and complications of botulinum A toxin in the treatment of blepharospasm","volume":"95","author":"Dutton","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib57","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archneur.1986.00520040060020","article-title":"Botulinum toxin in the management of blepharospasm","volume":"43","author":"Dutton","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1442-9071.2001.d01-28.x","article-title":"An evaluation of the safety and efficacy of botulinum toxin type A (BOTOX) when used to produce a protective ptosis","volume":"29","author":"Ellis","year":"2001","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib59","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/bjo.71.9.664","article-title":"Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections","volume":"71","author":"Elston","year":"1987","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib60","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0161-6420(87)33338-X","article-title":"Effectiveness of botulinum toxin therapy for essential blepharospasm","volume":"17","author":"Engstrom","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.moo.0000122308.13359.e6","article-title":"Botulinum toxin and the management of chronic headaches","volume":"12","author":"Evers","year":"2004","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib62","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/j.1468-2982.2004.00754.x","article-title":"Botulinum toxin A in the prophylactic treatment of migraine\u2014a randomized, double-blind, placebo-controlled study","volume":"24","author":"Evers","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.survophthal.2006.10.003_bib63","doi-asserted-by":"crossref","first-page":"6S","DOI":"10.1097\/01.PRS.0000082189.88054.35","article-title":"Botulinum toxin type A for facial aesthetic enhancement: role in facial shaping","volume":"112","author":"Fagien","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib64","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0733-8619(18)31090-9","article-title":"The varied clinical expressions of dystonia","volume":"2","author":"Fahn","year":"1984","journal-title":"Neurol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib65","first-page":"133","article-title":"Botulinum toxin type A: fine-tuning treatment of facial nerve injury","volume":"3","author":"Finn","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib66","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0733-8635(03)00070-6","article-title":"Myobloc","volume":"22","author":"Flynn","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib67","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clindermatol.2003.11.015","article-title":"Periocular botulinum toxin","volume":"21","author":"Flynn","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib68","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons","volume":"278","author":"Foran","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.survophthal.2006.10.003_bib69","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.58.12.1843","article-title":"Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of lid opening","volume":"58","author":"Forget","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib70","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1517\/13543784.13.11.1437","article-title":"The analgesic potential of clostridial neurotoxin derivatives","volume":"13","author":"Foster","year":"2004","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.survophthal.2006.10.003_bib71","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0161-6420(86)33641-8","article-title":"Treatment of facial spasm with botulinum toxin. An interim report","volume":"93","author":"Frueh","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib72","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1442-9071.1997.tb01272.x","article-title":"Botulinum toxin in fourth nerve palsies","volume":"25","author":"Garnham","year":"1992","journal-title":"Aust NZ J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib73","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1097\/00002508-200211001-00012","article-title":"Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes","volume":"18","author":"Glogau","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.survophthal.2006.10.003_bib74","first-page":"471","article-title":"[Treatment of sixth nerve palsy of traumatic or tumor etiology using botulinum toxin]","volume":"75","author":"Gomez De Liano Sanchez","year":"2000","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib75","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00002341-198601060-00005","article-title":"Treatment of hemifacial spasm with botulinum A toxin. Results and rationale","volume":"2","author":"Gonnering","year":"1986","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib76","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1749-6632.2002.tb04465.x","article-title":"Molecular analysis of SNAP-25 function in exocytosis","volume":"971","author":"Graham","year":"2002","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib77","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.51.6.767","article-title":"Blepharospasm: a review of 264 patients","volume":"51","author":"Grandas","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2006.10.003_bib78","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3928\/0191-3913-20010301-06","article-title":"Effect of botulinum toxin A chemodenervation in sensory strabismus","volume":"38","author":"Han","year":"2001","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2006.10.003_bib79","series-title":"Therapy with Botulinum Toxin","first-page":"103","article-title":"Immunogenicity of the neurotoxins of Clostridium botulinum","author":"Hathaway","year":"1994"},{"key":"10.1016\/j.survophthal.2006.10.003_bib80","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/0002-9394(88)90590-9","article-title":"Treatment of acquired nystagmus with botulinum A toxin","volume":"106","author":"Helveston","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib81","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.20098","article-title":"Clinical impact of antibody formation to botulinum toxin A in children","volume":"55","author":"Herrmann","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib82","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/00002341-200007000-00007","article-title":"Treatment of Frey's syndrome (gustatory sweating) and \u2018crocodile tears\u2019 (gustatory epiphora) with purified botulinum toxin","volume":"16","author":"Hofmann","year":"2000","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib83","first-page":"964","article-title":"Motor nerve sprouting in human orbicularis muscle after botulinum A injection","volume":"31","author":"Holds","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1091-8531(00)70003-6","article-title":"Botulinum toxin treatment versus conservative management in acute traumatic sixth nerve palsy or paresis","volume":"4","author":"Holmes","year":"2000","journal-title":"J AAPOS"},{"key":"10.1016\/j.survophthal.2006.10.003_bib85","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1091-8531(98)90081-7","article-title":"The natural history of acute traumatic sixth nerve palsy or paresis","volume":"2","author":"Holmes","year":"1998","journal-title":"J AAPOS"},{"key":"10.1016\/j.survophthal.2006.10.003_bib86","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0300-9084(00)00216-9","article-title":"How botulinum and tetanus neurotoxins block neurotransmitter release","volume":"82","author":"Humeau","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.survophthal.2006.10.003_bib87","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.2003.034702","article-title":"Botulinum toxin in clinical practice","volume":"75","author":"Jankovic","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2006.10.003_bib88","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1212\/01.WNL.0000055087.96356.BB","article-title":"Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia","volume":"60","author":"Jankovic","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib89","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp.64.6.751","article-title":"Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases","volume":"64","author":"Jitpimolmard","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.survophthal.2006.10.003_bib90","first-page":"280","article-title":"Intractable orbicularis myokymia: treatment alternatives","volume":"20","author":"Jordan","year":"1989","journal-title":"Ophthalmic Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3928\/0191-3913-20030101-09","article-title":"Subtenon injection of botulinum toxin for treatment of traumatic sixth nerve palsy","volume":"40","author":"Kao","year":"2003","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2006.10.003_bib92","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/bjo.86.1.43","article-title":"Botulinum toxin treatment for hyperlacrimation secondary to aberrant regenerated seventh nerve palsy or salivary gland transplantation","volume":"86","author":"Keegan","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib93","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/bi0356698","article-title":"Uptake of botulinum neurotoxin into cultured neurons","volume":"43","author":"Keller","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.survophthal.2006.10.003_bib94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1067\/mpa.2001.112679","article-title":"Botulinum toxin for sixth nerve palsies in children with brain tumors","volume":"5","author":"Kerr","year":"2001","journal-title":"J AAPOS"},{"key":"10.1016\/j.survophthal.2006.10.003_bib95","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0002-9394(02)02092-5","article-title":"Botulinum A toxin injection for restrictive myopathy of thyroid-related orbitopathy: effects on intraocular pressure","volume":"135","author":"Kikkawa","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib96","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1365-2133.2000.03839.x","article-title":"Effective treatment of frontal hyperhidrosis with botulinum toxin A","volume":"143","author":"Kinkelin","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib97","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.det.2004.02.001","article-title":"Botox for the eyes and eyebrows","volume":"22","author":"Klein","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib98","first-page":"610","article-title":"\u201cApraxia of lid opening,\u201d a focal eyelid dystonia: clinical study of 32 patients","volume":"10","author":"Krack","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.survophthal.2006.10.003_bib99","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1017\/S0317167100027748","article-title":"Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations","volume":"15","author":"Kraft","year":"1988","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib100","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0041-0101(80)90105-1","article-title":"Purification and some properties of H chain subunit of type A botulinum neurotoxin","volume":"18","author":"Krysinski","year":"1980","journal-title":"Toxicon"},{"key":"10.1016\/j.survophthal.2006.10.003_bib101","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.joms.2003.09.015","article-title":"The use of botulinum toxin type A in the treatment of Frey and crocodile tears syndromes","volume":"62","author":"Kyrmizakis","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib102","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ana.410320506","article-title":"Effectiveness of botulinum toxin administered to abolish acquired nystagmus","volume":"32","author":"Leigh","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib103","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-0420.1998.760106.x","article-title":"Treatment of strabismus and nystagmus with botulinum toxin type A. An evaluation of effects and complications","volume":"76","author":"Lennerstrand","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2006.10.003_bib104","first-page":"122","article-title":"The pupillary effects of retrobulbar injection of botulinum toxin A (oculinum) in albino rats","volume":"32","author":"Levy","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib105","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1097\/00002508-200211001-00005","article-title":"Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction","volume":"18","author":"Lew","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.survophthal.2006.10.003_bib106","doi-asserted-by":"crossref","unstructured":"Liu M, Lee HC, Hertle RW, Ho AC. Retinal detachment from inadvertent intraocular injection of botulinum toxin A. Am J Ophthalmol 137:201\u20132, 2004.","DOI":"10.1016\/S0002-9394(03)00837-7"},{"key":"10.1016\/j.survophthal.2006.10.003_bib107","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1067\/mjd.2002.124070","article-title":"Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feet","volume":"47","author":"Lowe","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib108","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.eye.6701307","article-title":"Successful management of three consecutive cases of recurrent corneal erosion with botulinum toxin injections","volume":"18","author":"Mackie","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2006.10.003_bib109","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2004.08.024","article-title":"Treatment of facial chromhidrosis with botulinum toxin type A","volume":"52","author":"Matarasso","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib110","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.35.10.1499","article-title":"Blepharospasm, Meige syndrome, and hemifacial spasm: treatment with botulinum toxin","volume":"35","author":"Mauriello","year":"1985","journal-title":"Neurology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib111","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3928\/0191-3913-20030901-10","article-title":"Incidence of stereopsis after treatment of infantile esotropia with botulinum toxin","volume":"40","author":"McNeer","year":"2003","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"Pt 1","key":"10.1016\/j.survophthal.2006.10.003_bib112","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/eye.1988.5","article-title":"Clostridium botulinum toxins: nature and preparation for clinical use","volume":"2","author":"Melling","year":"1988","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2006.10.003_bib113","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S1044-7431(02)00016-7","article-title":"Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation","volume":"22","author":"Meunier","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib114","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00002341-200405000-00001","article-title":"Botulinum toxin type a for dysthyroid upper eyelid retraction","volume":"20","author":"Morgenstern","year":"2004","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib115","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2273.1992.tb01831.x","article-title":"Management of facial synkinesis with Clostridium botulinum toxin injection","volume":"17","author":"Mountain","year":"1992","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib116","first-page":"105","article-title":"Botulinum A-toxin treatment of spasmodic entropion of the lower eyelid","volume":"224","author":"Neetens","year":"1987","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib117","first-page":"625","article-title":"[Botulinum toxin A in the treatment of congenital nystagmus in children]","volume":"106","author":"Oleszczy\u0144ska-Prost","year":"2004","journal-title":"Klin Oczna"},{"key":"10.1016\/j.survophthal.2006.10.003_bib118","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/bjo.82.5.528","article-title":"Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease","volume":"82","author":"Olver","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1526-4637.2005.05029.x","article-title":"Treatment of ptosis as a complication of botulinum toxin injection","volume":"6","author":"Omoigui","year":"2005","journal-title":"Pain Med"},{"key":"10.1016\/j.survophthal.2006.10.003_bib120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0039-6257(91)90207-V","article-title":"Botulinum A toxin (Oculinum) in ophthalmology","volume":"36","author":"Osako","year":"1991","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib121","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000310837","article-title":"Chemodenervation in treatment of upper eyelid retraction","volume":"211","author":"Ozkan","year":"1997","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.survophthal.2006.10.003_bib122","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1468-2982.2004.00738.x","article-title":"Treatment of chronic tension-type headache with botulinum toxin: a double-blind, placebo-controlled clinical trial","volume":"24","author":"Padberg","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.survophthal.2006.10.003_bib123","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14760584.3.4.477","article-title":"Progress toward development of an inhalation vaccine against botulinum toxin","volume":"3","author":"Park","year":"2004","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.survophthal.2006.10.003_bib124","series-title":"Advances in Neurology, Vol 49","first-page":"493","article-title":"Local side effects of botulinum toxin injections","author":"Patrinely","year":"1988"},{"key":"10.1016\/j.survophthal.2006.10.003_bib125","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0003-9993(97)90169-6","article-title":"Botulinum toxin treatment of apraxia of eyelid opening in progressive supranuclear palsy: report of two cases","volume":"78","author":"Piccione","year":"1997","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.survophthal.2006.10.003_bib126","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1001\/archopht.1994.01090220070025","article-title":"Treatment of acquired nystagmus with botulinum neurotoxin A","volume":"112","author":"Repka","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib127","first-page":"144","article-title":"[Crying upon eating: the crocodile-tears syndrome]","volume":"149","author":"Rodrigues Pereira","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.survophthal.2006.10.003_bib128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF01204598","article-title":"Orbicular synkinesis after facial paralysis: treatment with botulinum toxin","volume":"86","author":"Roggenkamper","year":"1994","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib129","first-page":"2001","article-title":"Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia","volume":"2\u20134","author":"Rollnik","year":"2001","journal-title":"Neurol Clin Neurophysiol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1442-9071.1994.tb01698.x","article-title":"Retrobulbar botulinum toxin for treatment of oscillopsia","volume":"22","author":"Ruben","year":"1994","journal-title":"Aust NZ J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib131","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0161-6420(94)31265-6","article-title":"The use of botulinum toxin for treatment of acquired nystagmus and oscillopsia","volume":"101","author":"Ruben","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib132","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3928\/0191-3913-20000701-05","article-title":"Botulinum treatment of infantile esotropia with abduction nystagmus","volume":"37","author":"Ruiz","year":"2000","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.survophthal.2006.10.003_bib133","first-page":"340","article-title":"Comparison of botulinum toxins A and B in the aesthetic treatment of facial rhytides","volume":"29","author":"Sadick","year":"2003","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib134","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0733-8635(03)00040-8","article-title":"Comparison of botulinum toxins A and B in the treatment of facial rhytides","volume":"22","author":"Sadick","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib135","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0002-9394(99)00408-0","article-title":"Effect of eyelid botulinum toxin injection on lacrimal drainage","volume":"129","author":"Sahlin","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5070\/D306G8W0MC","article-title":"The use of apraclonidine eyedrops to treat ptosis after the administration of botulinum toxin to the upper face","volume":"11","author":"Scheinfeld","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.survophthal.2006.10.003_bib137","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.pain.2004.01.016","article-title":"Treatment of chronic tension-type headache with botulinum toxin A: a randomized, double-blind, placebo-controlled multicenter study","volume":"109","author":"Schulte-Mattler","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.survophthal.2006.10.003_bib138","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pediatrneurol.2003.12.016","article-title":"Botulinum toxin B treatment in children with spastic movement disorders: a pilot study","volume":"31","author":"Schwerin","year":"2004","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib139","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0733-8635(03)00019-6","article-title":"Development of botulinum toxin therapy","volume":"22","author":"Scott","year":"2004","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.survophthal.2006.10.003_bib140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002341-199706000-00002","article-title":"Preventing ptosis after botulinum treatment","volume":"13","author":"Scott","year":"1997","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1016\/j.survophthal.2006.10.003_bib141","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00140912","article-title":"Injection treatment of endocrine orbital myopathy","volume":"58","author":"Scott","year":"1989","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib142","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib143","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000008152","article-title":"Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin","volume":"43","author":"Sedano","year":"2000","journal-title":"Eur Neurol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib144","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/sj.eye.6700690","article-title":"A single transcutaneous injection with Botox for dysthyroid lid retraction","volume":"18","author":"Shih","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2006.10.003_bib145","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0002-9394(14)77954-1","article-title":"The use of botulinum toxin in blepharospasm","volume":"99","author":"Shorr","year":"1985","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib146","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1076\/orbi.17.3.173.2748","article-title":"Botulinum toxin as adjunct for refractory compressive optic neuropathy in Graves' disease","volume":"17","author":"Simonsz","year":"1998","journal-title":"Orbit"},{"key":"10.1016\/j.survophthal.2006.10.003_bib147","first-page":"143","article-title":"The study of clostridial and related toxins. The search for unique mechanisms and common denominators","volume":"84","author":"Simpson","year":"1990","journal-title":"J Physiol (Paris)"},{"key":"10.1016\/j.survophthal.2006.10.003_bib148","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11910-001-0016-8","article-title":"The treatment of tics","volume":"1","author":"Singer","year":"2001","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.survophthal.2006.10.003_bib149","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1526-4610.2004.04148.x","article-title":"Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study","volume":"44","author":"Smuts","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.survophthal.2006.10.003_bib150","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0161-6420(97)30029-3","article-title":"Botulinum toxin management of childhood intermittent exotropia","volume":"104","author":"Spencer","year":"1997","journal-title":"Ophthalmology"},{"key":"10.1016\/j.survophthal.2006.10.003_bib151","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00055735-199410000-00005","article-title":"Nystagmus","volume":"5","author":"Spielmann","year":"1994","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib152","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0181-5512(04)96141-4","article-title":"[Botulinum toxin in infantile estropia: long-term results]","volume":"27","author":"Spielmann","year":"2004","journal-title":"J Fr Ophtalmol"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2006.10.003_bib153","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/eye.1997.128","article-title":"Botulinum toxin for\u00a0the temporary treatment of involutional lower lid entropion: a clinical and morphological study","volume":"11","author":"Steel","year":"1997","journal-title":"Eye"},{"key":"10.1016\/j.survophthal.2006.10.003_bib154","first-page":"133","article-title":"Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study","volume":"26","author":"Taylor","year":"1991","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib155","first-page":"2542","article-title":"Long-term outcome and predictor variables in the treatment of acquired esotropia with botulinum toxin","volume":"42","author":"Tejedor","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib156","first-page":"1189","article-title":"Botulinum A toxin therapy on esotropia in children","volume":"85","author":"Tengtrisorn","year":"2002","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.survophthal.2006.10.003_bib157","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1526-4610.2004.04147.x","article-title":"Botulinum neurotoxin type A in the preventive treatment of refractory headache: a review of 100 consecutive cases","volume":"44","author":"Tepper","year":"2004","journal-title":"Headache"},{"key":"10.1016\/j.survophthal.2006.10.003_bib158","first-page":"167","article-title":"Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins","volume":"84","author":"Thesleff","year":"1990","journal-title":"J Physiol (Paris)"},{"key":"10.1016\/j.survophthal.2006.10.003_bib159","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0002-9394(14)71236-X","article-title":"Unsatisfactory treatment of acquired nystagmus with retrobulbar injection of botulinum toxin","volume":"119","author":"Tomsak","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib160","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1034\/j.1600-0420.2001.790608.x","article-title":"Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction\u2014a pilot study","volume":"79","author":"Tr\u00e4isk","year":"2001","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.survophthal.2006.10.003_bib161","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0968-0004(02)02177-1","article-title":"Botulinum and tetanus neurotoxins: structure, function and therapeutic utility","volume":"27","author":"Turton","year":"2002","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.survophthal.2006.10.003_bib162","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/mds.10605","article-title":"Movement disorders in patients with peripheral facial palsy","volume":"18","author":"Valls-Sol\u00e9","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.survophthal.2006.10.003_bib163","first-page":"77","article-title":"Botulinum A toxin therapy in ophthalmology: a report of patients with facial dystonias","volume":"248","author":"Vissenberg","year":"1993","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"10.1016\/j.survophthal.2006.10.003_bib164","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1076\/orbi.22.3.193.15622","article-title":"The use of botulinum toxin A in the treatment of functional epiphora","volume":"22","author":"Whittaker","year":"2003","journal-title":"Orbit"},{"key":"10.1016\/j.survophthal.2006.10.003_bib165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0733-8635(03)00020-2","article-title":"Noncosmetic uses of botulinum toxin","volume":"22","author":"Zalvan","year":"2004","journal-title":"Dermatol Clin"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962570600172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003962570600172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:32:54Z","timestamp":1758540774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003962570600172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":165,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S003962570600172X"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2006.10.003","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum Toxin in Ophthalmology","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2006.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}